The patients are still being followed, which should reveal whether death rate will increase for the men assigned to monitoring. And that in turn adds to concern about screening with PSA blood tests, because screening is worthwhile only if finding cancer earlier saves lives.

The headline finding, summed up by Denise Grady of the New York Times, is that the researchers "found no difference in death rates" between men in the three groups over the span in question.

Generally, early stages of prostate cancer have no symptoms.

Douglas Collett, a retired construction worker from Cromhall, England, speaks about his prostate cancer diagnosis on Tuesday, Sept. 13, 2016. In recent years, the U.S. Preventive Services Task Force (USPSTF) essentially told men and their doctors that they did not need to be screened with a prostate-specific antigen (PSA) test because it just leads to more issues.

An enlarged prostate, also known as benign prostatic hyperplasia (BPH), presses against the urethra and makes it hard to pass urine. Nationally, more and more men are presenting with advanced and non-curable disease than at any time in the last 15 years.

Although evidence suggests otherwise, Brawley asserted that men can not bear to not undergo treatment whenever they are revealed that they have prostate cancer. "This is the first randomized trial ever conducted that compares surgery against radiation against surveillance in men with localized prostate cancer".

Paris climate deal draws closer after United Nations event
Ways of meeting this more stringent goal have been one of the central conversations at this year's Climate Week. Kerry said it was an "exciting moment" but warned that the threat posed by climate change grows every day.

The screening is in partnership with the Prostate Conditions Education Council (PCEC) and contributes to an ongoing clinical trial offering free prostate screenings once a year to men ages 40 - 75 who agree to take part in the PCEC trial.

Dr. Otis Brawley of the American Cancer Society, who was not involved in the research, said while men who waited for treatment were twice as likely to have their cancer spread, it was nonetheless a very low number. Noting that the men enrolled in the study had low-risk cancer (Gleason score 6, PSA 10 ng/mL), Hu said, "For men I see with low-risk disease, I always offer active monitoring, or active surveillance".

In addition, the average PSA (prostate-specific antigen) of men who were diagnosed with metastatic prostate cancer in 2013 was 49, almost double that for men diagnosed in 2004 with an average PSA of 25, indicating a greater extent of disease at diagnosis. We learn, importantly that he "dreaded the possibility of side effects of surgery or radiation, including incontinence and impotence".

Dr. Brawley does not discard treating prostate cancer aggressively, but he explains that there are many cases that do not require treatments that could hassle the patients' daily lives. Did you know that in the United States, prostate cancer is one of the most common cancers in men; regardless of ethnicity or race? When it comes to what we consume, there is research that suggests cutting back on red and processed meats. limiting high fat foods, and eating a diet rich in fruit and veggies may be effective. The study found no significant differences in prostate cancer mortality between the three groups. High level can be a red flag for prostate cancer, but can also signal natural growth with age. The guidelines recommended against PSA testing for men who had never been diagnosed with the disease because the benefits are too small and the risk of harm is too great.

The active surveillance arm also had a higher rate of disease progression, 112 patients versus 46 each in the surgery and radiotherapy groups. "What we need to clarify is who will develop metastases and disease progression", said Hu. "Because of its improved precision, patients and physicians are better informed to choose the most appropriate treatment".

The data apparently hint that treatments have some advantage over watchful waiting (watchful waiting - regularly monitored and intervened only when needed). The test can result in "false positives", or encourage aggressive treatment of malignancies that are so slow-growing that they aren't a threat.